GenMont Biotech Incorporation (3164.TW)

TWD 19.95

(-0.5%)

Market Cap (In TWD)

1.72 Billion

Revenue (In TWD)

318.01 Million

Net Income (In TWD)

32.99 Million

Avg. Volume

52.52 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.85-25.35
PE
-
EPS
-
Beta Value
0.358
ISIN
TW0003164000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Yu Chin Chen
Employee Count
-
Website
https://www.genmont.com.tw
Ipo Date
2008-09-19
Details
GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.